Navigation Links
Single-celled bacterium works 24-7
Date:4/28/2008

search team examined the expression of 5,000 genes, measuring the amount of messenger RNA for each gene in alternating dark and light periods over 48 hours. At a given time, the mRNA levels indicated what the cells were doing. For example, when the researchers identified high levels of many mRNAs encoding various protein components of the nitrogenase enzyme, they knew that the cells were fixing nitrogen at that time, in this case, during the dark periods.

Of the 5,000 genes studied, nearly 30 percent cycled on and off with changing light and dark periods. These particular genes, the study found, also govern major metabolic processes. Therefore, the cycling of mRNA transcription, Pakrasi said, provides deep insight into the physiological behavior of the organism -- day and night.

During the day, Cyanothece busies itself with photosynthesis. Using energy from sunlight, carbon dioxide from the atmosphere, and water, Cyanothece produces glucose, a sugar it stores in glycogen granules, filling its chemical gas tank. At night, the Cyanothece ramps up production of nitrogenase to fix nitrogen, as expected. Since nitrogen fixation requires a lot of energy, Cyanothece uses the glycogen stored in its chemical gas tank through a process called respiration. Because respiration requires oxygen, the cells conveniently use up this by-product of photosynthesis, likely helping to protect nitrogenase from degradation.

Through this cyclic expression of genes, Cyanothece is essentially a living battery, storing energy from the sun for later use. This feat continues to elude scientists searching for ways to harness sunlight and produce energy on a large scale. With this in mind, a new project for the Pakrasi team seeks to use the machinery of Cyanothece -- its energy storage strategy, its anaerobic conditions that protect important enzymes -- as a biofactory to produce hydrogen from sunlight, the ultimate clean energy source.


'/>"/>

Contact: Gayle Geren
geren@wustl.edu
314-935-7163
Washington University in St. Louis
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Bacterium sequenced makes rare form of chlorophyll
2. Researchers decode genetics of rare photosynthetic bacterium
3. Rain forest protection works in Peru
4. MIT works toward safer gene therapy
5. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
6. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
7. Alternative food networks connect ethical producers and consumers and can lead to healthier eating
8. Workshops on biotechnology and water for science journalists
9. MIT works toward engineered blood vessels
10. Solidus Networks, Inc. Seats New Board of Directors
11. ESFs workshop restores good name of sugar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2014)... 9, 2014  Wake Forest Baptist Medical Center today announced ... School of Medicine. Funding for this $50 million capital ... will be publicly launched next summer. ... former 60 series R.J. Reynolds Tobacco Company complex, adjacent ... begin immediately with plans to be ready to welcome ...
(Date:12/10/2014)... December 9, 2014   ... Platform   Jifflenow, ... scheduling solutions for business-to-business (B2B) events, today announced ... in mobile near-field communication (NFC), Bluetooth low energy ... (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate ...
(Date:12/4/2014)... BEACH GARDENS, Fla. , Dec. 3, 2014 ... management solutions, today announced that its DigitalPersona ® ... 4500 fingerprint readers have been deployed throughout First ... , South Carolina ... headquartered in Southern Pines, North Carolina ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... Virology of the GSF National Research Center for ... Research Centres) the group is continuing to search for ... of a prion infection. In collaboration with colleagues from ... Heidelberg, the group used micro-array technologies micro-arrays ...
... plant cell biologist at UC Riverside has received a ... investigate how plant stem-cells maintain their identity and how ... According to G. Venugopala Reddy, the principal investigator of ... on plants, has potential to lead to better insights ...
... infant formula-- may reduce a babys susceptibility to rotavirus ... a University of Illinois study published in Septembers Journal ... diarrhea in infants, affecting virtually all children before age ... dehydration, doctors visits, and parents missing work to care ...
Cached Biology News:Prions and retroviruses -- an unholy alliance? 2UCR plant cell biologist to study how plant stem cells maintain and change their identity 2Soy isoflavone may inhibit common gastrointestinal illness in infants 2
(Date:12/17/2014)... Gene synthesis and bioengineering company ... into a technology access and services agreement with ... proprietary protein engineering technology, known as “ProteinGPS®” to ... extremely excited that the global leader ADM has ... bioengineering technology has now been validated through many ...
(Date:12/17/2014)... 17, 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of innovative therapeutics addressing cancer ... with a primary commercial focus on China ... a Type C meeting with the U.S. Food and ... held in February 2015.  During this meeting the Company ...
(Date:12/15/2014)... Israel , Dec. 15, 2014  BrainStorm ... leading developer of adult stem cell technologies for neurodegenerative ... Ltd. was awarded a grant of approximately $1.1 million ... Chief Scientist (OCS).  This is the eighth year that ... the Office of the Chief Scientist, which is part ...
(Date:12/15/2014)... , Dec. 15, 2014  Ascendis Pharma A/S, ... technology to address significant unmet medical needs, today ... Phase 2 pediatric study to evaluate once-weekly TransCon ... or GHD.  This interim analysis consists of 25 ... enrollment in the study, completing all six months ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4
... Candidate Enters Clinical Trials, REDWOOD CITY, Calif., ... novel antibody therapeutics that target,cancer stem cells, today ... its Series B financing round, raising $93 million. ... $154 million. New investor Nomura,Phase4 Ventures participated in ...
... study success at Berlin conference, RALEIGH, N.C., ... Organization announces it will present during the,Partnerships in ... in Berlin,Germany. PRA,s Christian Tucat, Senior Vice President ... in the evolution of CRO,partnerships?" at 4PM on ...
... (NTI(R)) (Nasdaq: NTII ), today announced it will ... ended September,30, 2008, and host a conference call on ... Paul E. Freiman, President and Chief Executive,Officer, and Matthew ... for the call are as follows:, Live ...
Cached Biology Technology:OncoMed Pharmaceuticals Completes Series B Financing 2OncoMed Pharmaceuticals Completes Series B Financing 3PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress 2Neurobiological Technologies Sets Date for First Quarter Financial Results 2
...
Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
Goat anti-VAV2 Class: Antibody Product Group: Miscellaneous Antibody...
Rabbit polyclonal to M13 Bacteriophage Coat Proteins ( Abpromise for all tested applications)....
Biology Products: